Cell culture process technology platform provides for the optimization of media, seeding densities, feeding and bioreactor process control strategies to maximize expression, and enhances process reproducibility and facilitate scale-up Adaption of cell line to...
Cell line development from DNA sequences to RCB stability assessment Traceability of host cell history and cell line generation process High productivity and robust stable cell line development platforms Well-equipped cell line development labs and clone...
Watch our on-demand webinar: Biological Macromolecules: Exploring Analytical Development and QC Case Studies in Antibody Developability and Biologics CMC Presented by Dr. Jinghan Su, Assistant Director and Head of Developability, and Dr. Qian Sun, Director, Head of...
Pilot scale capacities in Zhangjiang, Shanghai Capable of generating 500-1000g of DS per batch to meet pre-IND and phase I &II clinical demand Aseptic fill 2- 20 ml vials, up to 900-1800 vial/hr and 5000 vials per batch; 2.8m² freeze-drying shelf area for DP GMP...
Our biologics analytical capability includes both analytical development and testing for non-GMP samples and QC testing and releases for GMP drug substances and drug product. Our rapidly growing Analytical Development & Quality Control team comprises 40+...
English 
Chinese